drugset / Trial / NCT00003262

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

NCT00003262

Phase 2 Unknown 30 enrolled Centro di Riferimento Oncologico - Aviano
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of two combination chemotherapy regimens in treating patients with Hodgkin's disease and HIV infection.

Timeline

Start
1997-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Intramuscular
Subject Doxorubicin Other / unclassified Intravenous
Subject Epirubicin Small molecule Intravenous
Subject Etoposide Small molecule Intravenous
Subject Prednisone Other / unclassified Oral
Subject Vinblastine Small molecule Intravenous
Subject Vincristine Small molecule Intravenous
Subject mechlorethamine Small molecule Intravenous
Background filgrastim Protein / enzyme biologic

Indications